Submitting OIG:
Report Description:
For a covered outpatient drug to be eligible for Federal reimbursement under the Medicaid program's drug rebate requirements, manufacturers must pay rebates to the States for the drugs. However, previous OIG audits found that States did not always bill and collect all rebates due for drugs administered by physicians.
Date Issued:
Tuesday, July 21, 2020
Agency Reviewed / Investigated:
Submitting OIG-Specific Report Number:
A-09-19-02001
Component, if applicable:
Centers for Medicare & Medicaid Services
External entity, if applicable:
State of Alaska
Location(s):
AK
United StatesType of Report:
Audit
Questioned Costs:
$1,013,253
Number of Recommendations:
6
View Document:
Attachment | Size |
---|---|
A-09-19-02001.pdf | 1.99 MB |
Additional Details Link: